'Gleevec is under patent in the U.S., but not in India' This is a biased article, Novartis tried to gain one more patent for existing drug with slight modification.

see 'Calling big pharma's bluff' http://www.thehindu.com/opinion/lead/calling-big-pharmas-blu...